LifeVantage Corporation Insider Trading

LFVN

Last 12 months

Insiders bought 196K and sold 472K on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Michael A Beindorff sold 250K on Nov 7, 2025, 27% of their stake, outside a plan.

Net open-market

−276K

6 buys · 4 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

2 / 2

executives and directors

Last open-market buy

Sep 2026

Sep 15, 2026

Get an email when LFVN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 15	Darwin Lewis Director	Bought	976	$6.22	6K	0.7%	Form 4
Sep 11 – 14	Kristen Cunningham Chief Sales Officer	SoldNo plan 2 parts	9,001	$6.18 average	56K	7.0%	Form 4
Jun 15	Darwin Lewis Director	Bought	705	$8.60	6K	0.5%	Form 4
Jun 3	Michael A Beindorff Director	SoldNo plan	10,000	$8.55	86K	12%	Form 4
Mar 16	Darwin Lewis Director	Bought	1,055	$5.23	6K	0.8%	Form 4
Feb 26 – Mar 2	Judd Dayton Director	Bought 3 parts	33,197	$4.59 average	152K	4.2%	Form 4
Feb 9	Darwin Lewis Director	Bought	3,955	$5.22	21K	3.0%	Form 4
Dec 15, 2025	Darwin Lewis Director	Bought	805	$6.54	5K	0.6%	Form 4
Nov 19, 2025	Michael A Beindorff Director	SoldNo plan	12,607	$6.42	81K	13%	Form 4
Nov 7, 2025	Michael A Beindorff Director	SoldNo plan 2 parts	36,000	$6.93 average	250K	27%	Form 4
Sep 16, 2025	Darwin Lewis Director	Bought	450	$10.85	5K	0.4%	Form 4
Sep 9, 2025	Michael A Beindorff Director	SoldNo plan 2 parts	4,325	$11.44 average	49K	3.5%	Form 4
Jul 1, 2025	Carl Aure Chief Financial Officer	SoldNo plan	2,746	$13.39	37K	2.0%	Form 4
Jun 13, 2025	Darwin Lewis Director	Bought 2 parts	379	$12.86 average	5K	0.3%	Form 4
May 9, 2025	Garry Paul Mauro Director	Bought 7 parts	2,150	$12.25 average	26K	0.8%	Form 4
Feb 10, 2025	Raymond B Greer Director	SoldNo plan	8,000	$20.15	161K	7.5%	Form 4
Feb 10, 2025	Cynthia Latham Director	SoldNo plan	4,450	$20.02	89K	8.0%	Form 4
Feb 10, 2025	Michael A Beindorff Director	SoldNo plan	5,850	$19.54	114K	4.5%	Form 4
Dec 16, 2024	Darwin Lewis Director	Bought	227	$16.00	4K	0.2%	Form 4

Sep 15
Darwin Lewis
Director · bought 976 at $6.22
6K
0.7% of stake
Sep 11 – 14No plan
Kristen Cunningham
Chief Sales Officer · sold 9,001 at avg $6.18
56K
7.0% of stake
Jun 15
Darwin Lewis
Director · bought 705 at $8.60
6K
0.5% of stake
Jun 3No plan
Michael A Beindorff
Director · sold 10,000 at $8.55
86K
12% of stake
Mar 16
Darwin Lewis
Director · bought 1,055 at $5.23
6K
0.8% of stake
Feb 26 – Mar 2
Judd Dayton
Director · bought 33,197 at avg $4.59
152K
4.2% of stake
Feb 9
Darwin Lewis
Director · bought 3,955 at $5.22
21K
3.0% of stake
Dec 15, 2025
Darwin Lewis
Director · bought 805 at $6.54
5K
0.6% of stake
Nov 19, 2025No plan
Michael A Beindorff
Director · sold 12,607 at $6.42
81K
13% of stake
Nov 7, 2025No plan
Michael A Beindorff
Director · sold 36,000 at avg $6.93
250K
27% of stake
Sep 16, 2025
Darwin Lewis
Director · bought 450 at $10.85
5K
0.4% of stake
Sep 9, 2025No plan
Michael A Beindorff
Director · sold 4,325 at avg $11.44
49K
3.5% of stake
Jul 1, 2025No plan
Carl Aure
Chief Financial Officer · sold 2,746 at $13.39
37K
2.0% of stake
Jun 13, 2025
Darwin Lewis
Director · bought 379 at avg $12.86
5K
0.3% of stake
May 9, 2025
Garry Paul Mauro
Director · bought 2,150 at avg $12.25
26K
0.8% of stake
Feb 10, 2025No plan
Raymond B Greer
Director · sold 8,000 at $20.15
161K
7.5% of stake
Feb 10, 2025No plan
Cynthia Latham
Director · sold 4,450 at $20.02
89K
8.0% of stake
Feb 10, 2025No plan
Michael A Beindorff
Director · sold 5,850 at $19.54
114K
4.5% of stake
Dec 16, 2024
Darwin Lewis
Director · bought 227 at $16.00
4K
0.2% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch LFVN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with LFVN

CompareIntrinsic value

MGNXMacrogenics Inc.

$2.31-0.86%36

ABUSArbutus Biopharma Corporation

$4.06+4.64%60

AMRNAmarin Corp PLC\Uk

$12.25+1.66%46

CYRXCryoport Inc.

$16.70+1.52%13

URGNUrogen Pharma Ltd.

$28.71-16.54%30

SLNOSoleno Therapeutics Inc

No recent price25

NUVBNuvation Bio Inc.

$4.73+0.85%10

DAWNDay One Biopharmaceuticals, Inc.

No recent price10

Held by ETFs

LFVN is in 5 US ETFs. The largest of them, with LFVN's weight in each:

Spot a number that looks wrong? Check it in LFVN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LFVN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.